A
Ali Mirzapour
Researcher at Babol University of Medical Sciences
Publications - 5
Citations - 52
Ali Mirzapour is an academic researcher from Babol University of Medical Sciences. The author has contributed to research in topics: Bone mineral & Type 2 diabetes. The author has an hindex of 2, co-authored 5 publications receiving 34 citations.
Papers
More filters
Journal ArticleDOI
Salivary flow rate and xerostomia in patients with type I and II diabetes mellitus.
TL;DR: Type I, II diabetic patients revealed lower salivary flow rate and higher xerostomia compared with healthy controls, which had inverse correlation.
Journal ArticleDOI
The Effect of Urtica dioica Hydro-Alcoholic Extract on Glycemic Index and AMP-Activated Protein Kinase Levels in Diabetic Patients: A Randomized Single-Blind Clinical Trial
TL;DR: According to the results, UD is able to decrease glucose level and improve insulin release in T2DM and it is possible that the anti-hyperglycemic eect of UD is mediated by insulin secretion and the possible changes in AMPK levels.
Journal ArticleDOI
Hyponatremia, bone mineral density and falls in the elderly; Results from AHAP study.
Seyed Reza Hosseini,Naghi Baghitabar,Ali Mirzapour,Farshid Oliaei,Hajighorban Nooreddini,Ali Bijani,Simin Mouodi +6 more
TL;DR: HN was not a prevalent problem in older adults who met the inclusion criteria of this research and no significant difference has been observed between HN and bone mineral density and falls in the elderly.
Journal ArticleDOI
The relationship between serum uric acid and blood sugar levels in the elderly diabetic patients of amirkola city
TL;DR: FBS is inversely correlated with the serum uric acid and age whereas there is a direct correlation between BMI and FBS.
Correlation between Thyroid Function and Bone Mineral Density in Elderly People
Ali Mirzapour,Fatemeh Shahnavazi,Ahmad Karkhah,Seyed Reza Hosseini,Hajighorban Noreddini,Ali Bijani +5 more
TL;DR: This paper presents a meta-analysis of 125 cases of central nervous system disorder in eight patients treated with a single treatment over a 12-week period at the Babol University of Medical Sciences in Babol, Iran.